Cas no 1142192-03-7 (methyl 6-bromo-2-chloropyridine-3-carboxylate)
methyl 6-bromo-2-chloropyridine-3-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- Methyl 6-bromo-2-chloronicotinate
- Methyl 6-bromo-2-chloronicotite
- methyl 6-bromo-2-chloropyridine-3-carboxylate
- CS-0081031
- A894242
- MFCD11857730
- DB-370964
- SY250171
- D74278
- DTXSID30673923
- BS-19257
- Methyl 6-bromo-2-chloronicotinate, AldrichCPR
- SCHEMBL22717309
- Methyl6-bromo-2-chloronicotinate
- AKOS015835758
- 3-Pyridinecarboxylic acid, 6-bromo-2-chloro-, methyl ester
- 1142192-03-7
-
- MDL: MFCD11857730
- Inchi: 1S/C7H5BrClNO2/c1-12-7(11)4-2-3-5(8)10-6(4)9/h2-3H,1H3
- InChI Key: RSFOIRKITQYSLT-UHFFFAOYSA-N
- SMILES: BrC1=CC=C(C(=O)OC)C(=N1)Cl
Computed Properties
- Exact Mass: 248.91900
- Monoisotopic Mass: 248.91922g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 179
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.7
- Topological Polar Surface Area: 39.2?2
Experimental Properties
- PSA: 39.19000
- LogP: 2.28410
methyl 6-bromo-2-chloropyridine-3-carboxylate Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
methyl 6-bromo-2-chloropyridine-3-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | M166091-1g |
methyl 6-bromo-2-chloropyridine-3-carboxylate |
1142192-03-7 | 97% | 1g |
¥3170.90 | 2023-09-02 | |
| Alichem | A025019817-1g |
Methyl 6-bromo-2-chloro-3-pyridinecarboxylate |
1142192-03-7 | 95% | 1g |
$712.98 | 2023-09-04 | |
| Chemenu | CM176832-1g |
Methyl 6-bromo-2-chloronicotinate |
1142192-03-7 | 95% | 1g |
$701 | 2021-08-05 | |
| TRC | M295438-25mg |
Methyl 6-Bromo-2-chloronicotinate |
1142192-03-7 | 25mg |
$75.00 | 2023-05-18 | ||
| TRC | M295438-50mg |
Methyl 6-Bromo-2-chloronicotinate |
1142192-03-7 | 50mg |
$110.00 | 2023-05-18 | ||
| TRC | M295438-100mg |
Methyl 6-Bromo-2-chloronicotinate |
1142192-03-7 | 100mg |
$155.00 | 2023-05-18 | ||
| TRC | M295438-250mg |
Methyl 6-Bromo-2-chloronicotinate |
1142192-03-7 | 250mg |
$287.00 | 2023-05-18 | ||
| TRC | M295438-500mg |
Methyl 6-Bromo-2-chloronicotinate |
1142192-03-7 | 500mg |
$454.00 | 2023-05-18 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 035729-100mg |
Methyl 6-bromo-2-chloronicotinate |
1142192-03-7 | 100mg |
1608.0CNY | 2021-08-03 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 035729-500mg |
Methyl 6-bromo-2-chloronicotinate |
1142192-03-7 | 500mg |
5623.0CNY | 2021-08-03 |
methyl 6-bromo-2-chloropyridine-3-carboxylate Related Literature
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
Additional information on methyl 6-bromo-2-chloropyridine-3-carboxylate
Methyl 6-Bromo-2-Chloropyridine-3-Carboxylate (CAS 1142192-03-7): A Versatile Building Block in Modern Organic Synthesis
In the realm of heterocyclic chemistry, methyl 6-bromo-2-chloropyridine-3-carboxylate (CAS 1142192-03-7) has emerged as a crucial intermediate with wide-ranging applications. This pyridine derivative combines multiple reactive sites - a bromo group at position 6, a chloro substituent at position 2, and an ester functionality at position 3 - making it exceptionally valuable for pharmaceutical synthesis and material science applications.
The molecular structure of 6-bromo-2-chloropyridine-3-carboxylic acid methyl ester offers unique opportunities for sequential functionalization, a feature that has attracted significant attention from medicinal chemists. Recent trends in drug discovery highlight the growing demand for such multifunctional pyridine building blocks, particularly in the development of kinase inhibitors and central nervous system (CNS) drugs.
From a synthetic perspective, the bromine atom in methyl 6-bromo-2-chloro-nicotinate readily participates in various cross-coupling reactions, including Suzuki, Stille, and Buchwald-Hartwig couplings. This reactivity profile aligns perfectly with current industry needs for efficient C-C bond formation strategies. Meanwhile, the chloro substituent offers additional possibilities for nucleophilic aromatic substitution (SNAr) reactions, making this compound a true multitool for molecular construction.
Recent advancements in catalyzed coupling reactions have further enhanced the utility of methyl 6-bromo-2-chloropyridine-3-carboxylate in high-throughput synthesis. Pharmaceutical researchers particularly value its role in creating structure-activity relationship (SAR) libraries, where rapid diversification of core structures is essential. The compound's stability under various reaction conditions makes it ideal for parallel synthesis approaches that dominate modern drug discovery pipelines.
The ester functionality in 6-bromo-2-chloropyridine-3-carboxylic acid methyl ester provides additional synthetic handles, allowing straightforward conversion to amides, acids, or reduced alcohol derivatives. This versatility addresses one of the most common search queries among synthetic chemists: "how to modify pyridine carboxylates for specific applications." The compound's balanced reactivity profile makes it particularly suitable for late-stage functionalization strategies that are currently revolutionizing medicinal chemistry workflows.
In material science applications, methyl 6-bromo-2-chloropyridine-3-carboxylate serves as a precursor for various functional materials, including organic semiconductors and coordination complexes. The growing interest in pyridine-based materials for optoelectronic devices has created new demand for such carefully functionalized intermediates. Researchers working on metal-organic frameworks (MOFs) also frequently search for halogenated pyridine derivatives like this compound for their unique coordination properties.
From a commercial availability perspective, methyl 6-bromo-2-chloronicotinate has become more accessible in recent years, reflecting its growing importance in both academic and industrial settings. Suppliers typically offer this compound with high purity (>97%), meeting the stringent requirements of pharmaceutical development. The compound's shelf stability and well-characterized properties make it a reliable choice for various chemical transformations.
Quality control of methyl 6-bromo-2-chloropyridine-3-carboxylate typically involves HPLC analysis and 1H/13C NMR characterization, ensuring batch-to-batch consistency for critical applications. These analytical protocols align with current good manufacturing practice (cGMP) standards when used in pharmaceutical intermediate production. The compound's well-defined spectroscopic features also make it an excellent candidate for reaction monitoring studies using modern analytical techniques.
Environmental and handling considerations for 6-bromo-2-chloropyridine-3-carboxylic acid methyl ester follow standard laboratory safety protocols for organic compounds. While not classified as highly hazardous, proper personal protective equipment (PPE) including gloves and eye protection is recommended when handling this material, as with most halogenated compounds. These safety aspects are particularly important given the increasing focus on green chemistry principles in modern laboratories.
The future outlook for methyl 6-bromo-2-chloropyridine-3-carboxylate appears promising, especially considering the sustained interest in halogenated heterocycles across multiple research fields. As synthetic methodologies continue to evolve, particularly in C-H activation and photocatalysis, the strategic value of such carefully functionalized building blocks will likely increase. This aligns with broader industry trends toward more efficient and atom-economical synthetic routes.
For researchers considering methyl 6-bromo-2-chloronicotinate for their projects, the compound offers an excellent balance of reactivity and stability. Its multiple functional groups enable diverse molecular editing possibilities while maintaining sufficient robustness for various synthetic operations. These characteristics explain why this particular pyridine derivative continues to appear in patent literature and research publications across multiple chemistry subdisciplines.
1142192-03-7 (methyl 6-bromo-2-chloropyridine-3-carboxylate) Related Products
- 65169-43-9(Methyl 2-chloro-5-methylnicotinate)
- 65515-28-8(Methyl 2,6-dichloronicotinate)
- 78686-79-0(methyl 5-bromo-2-chloropyridine-3-carboxylate)
- 1452-94-4(ethyl 2-chloropyridine-3-carboxylate)
- 1125410-08-3(6-bromo-2-chloro-pyridine-3-carbaldehyde)
- 40134-18-7(methyl 2-chloropyridine-3-carboxylate)
- 1214377-13-5(Ethyl 2-bromo-6-chloronicotinate)
- 1060815-67-9(6-Bromo-2-chloronicotinic acid)
- 1214335-05-3(Methyl 2-bromo-6-chloronicotinate)
- 1214335-22-4(Ethyl 6-bromo-2-chloronicotinate)